Member Info for GIVMESUNSHINE

My personal expectation was to see cirt gain modest traction since the last update - however many on here were expecting 4 fold rise in 6 months, and no need for funding - that was not based on any facts, or any guidance from the company. So for me its took a blip ... Cirt was dissapointing I do feel he ramped it in august and its not quite happened yet, but the process of now going to bigger groups with case studies has been stated as a strategy for a long time and is now also happening , that not a panic move - PSE numbers were not relevant better than i thought, as mentioned the PSE was delivered early and most PI's bought in on that news, Code and lab all very quick and delivered early so cant fault that side of the buisness most AIM Bios never meet a programme date, you never get a medi code in 3 months, so they know what they are doing .. BUPA will bear fruit this year. Cirt potentilal had been clear from August and the SP didnt move.. plenty to happen over the coming months and this year .. what they have achieved over a calendar year is inpressive IMO .. just let down by cirt nos

Mikey - I agree - Cirt was disspointing, yes.. and i must admit it exposed weaknessin Jon, but funding was always needed, couldnt have been spelt out clearer in August. It will be interesting to see if any major holders adjust thier positions , doesnt change the tests and as far as PSE is conerned 40-50 in decemenber was OK. Im holding off doing anything untill the dummies have all been thrown out of the pram .. There was only a few on here until the lead in to the results..

404x - you are wrong on that front - have you read the cancers journal that's not what it concludes at all - it concludes that PSE is suitable for use in screening in high risk population , but further trials would be necessary to confirm expansion of this further to low risk groups. That itself leads to OBD target market for the test. If you thought that why did you buy in ? Sound foolish

For all we know Mr Arrivo was strong armed into the buisness also, jurys out for now.

I know everyone is dissapointed with the numbers - I am , however i do think there needs to be some balance betwenn golden ticket and going bankrupt in a matter of a week.

Firstly on funding - there comapny has always stated , based on projections it will need funding in Q2 that has only changed in the minds PI's.. However confidence has taken a big knock because of the drop in CIRT, but again we are early days in the terms of execution , its not an easy task , no matter how good the product is, The BUPA deal is a massive endorsement, but again did people expect them to fly out the door when dealing with a multinational ? Company even state in the may results that they were working with one of the BIggest UK insurers, but didnt expect the deal to contibute straight away. . Getting PSE released and codedin 6 months is very impressive. and its way to early to call PSE some kind of failure .. tad over 2 tests a day in Dec - so 50 last month, that only another £30k a month.. but its way way to early, deal with larger groups will take some time, may be one tomorrow . Plus we have the other tests.. So in terms of funding that will not be a problem - nearly 50% of stock tightly held by large shareholders with much more skin in the game ..However they may demand some changes.. For me Jon came across very poorly .. bluffing instead of admitting certain things have not gone to plan , showed he was more interest in his own ego than being accountable. Time will tell , funding may already being finalised .. Potential v risk

Hi All.

Looking through the accounts - Net Cash used in H2 was £3 million compared to £5.2 million in H1 - we have had quite a bit of sunk cost as well over the period. The rest is non cash depreciation etc.

Hi Dibs - Oh this does matter.. I'm with you on what I hoped for, Its took a hit and i'm not happy. I'm putting it into context with todays SP.. There too much going on and developments can happen at any point - they certainly have done well getting PSE to code and launch within 9 months - PSE caused the SP to spike - but Cirt was more important to me

Fully Agree - but that is a target / expectation set by posters on the BB's - OBD have alway stated based on thier (unknown) targets they will need funding Q224 .. Dont get me wrong - I wanted to se 160 ish+ plus .. and thats been missed by some margin and it has done damage to the SP, but its not a lights out senrio .time will tell.. they have a plan and they appear to have the right people.

404 - No its true, only speculators stating funding wont be need OBD have been fully upfront on that .. Ive known that .. Read Aug RNS ..only a fool would have thought they would not need funding - Even at 200 CIRT test and month they would still need it Q2.. Not saying what the share price will do - but funding needs have always been stated.

OBD have always stated they will need funding in Q2 2024 - that was in the last Aug fundraise docs.. so on that front there is no suprise at all .. It would have been much better to see those CIRT Sales up in the 3 digits to show the plan is fully on track. All about confidence..

404x There is a very large intitutional shareholder base..Just north of 50% are in singular holdings over 3% its not going to run out of cash at this stage of commercialsation ..way to much to take into account. look at the volume in the run up .. all that is no churning IMO -

TBH - I dont think the round number large trades have been sells, Can never tell - but if a big holder was to sell they wouldnt do it on a PI Frenzy spike. robbing themselves

I havent trashed it - Was very dissapointed with the update - I Still am, however there no need to be silly... IP is worth much more than SP and they have done many things very well - BUPA, MEDICARE CODES, LAB CERT, etc - Overeation .. so its a value based judgement for me - too much hot money in before the results and now we are getting the pain.

While there is alot of hysteria - I think its overdone - Dissapointed with the numbers but Alot going for OBD - Lesson learned but its well worth 20p a share .. Will hold back adding more, but on balance with a calm head its worth adding to at these levels

A positive to take from todays update is that the PSE tests averaged over 2 day in Dec - so about 50 tests .. with 85% being insured users .. whilst its not more than 20-30k a month revenue - it does demonstrate how easily PSE can penetrate compared to Cirt - that's just off a generic code and very new .. so after a couple of months it's doing almost the same amount of test as Cift ( all be at 1/3 of the cost ) however that's off a very low base and would not take much at all to get in the high 100's a month

I think they have made its clear they are in the process of building the files /evidence needed to get the big insurers and hospital groups onboard - Im fine with the route and processess being put in place - they do seem to be going about it in the right way .. just need to get those numbers up .. There alot that could happen on the positive side over the next few month -evolving story, TBD

All the questions I posted during the live Q+A Zoom were answered (not quite to my satisfaction) - but answered

Dug Sorry but its wasnt hard to read, you just saw what you wanted to see.

However, All in all a dissapointing update, but with plenty oging on - TBF DIBs on the progress side (time to get the tests to market , Lab, BUPA, Codes etc) OBD have been very impressive , sometimes you sit for years waiting for trhese to come to fuition..I think the Dossier of real life results was alway stated as the plan, and good to see that moving along.. but i do concour with the XIRT numbers - its tempered my enthuiasm compared to jon's .D

Oh Ok - Its a ponder for me - I'm not adding at the monmrt but there too much short - mid term potential to risk not having this in my holdings .. no lack of positivity from Jon and I think we all see the "vision" very interesting , but dissapointed with the Cirt numbers myself. Lots to look forwards too

190?